Alkermes
ALKS
#2598
Rank
โ‚ฌ6.11 B
Marketcap
36,45ย โ‚ฌ
Share price
1.80%
Change (1 day)
33.81%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2026 (TTM): โ‚ฌ0.20 Billion

According to Alkermes's latest financial reports the company's current earnings are โ‚ฌ1.56 Billion. In 2025 the company made an earning of โ‚ฌ0.27 Billion a decrease over its 2024 earnings that were of โ‚ฌ0.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ0.20 B-25.81%
2025 โ‚ฌ0.27 B-34.87%
2024 โ‚ฌ0.41 B-17.97%
2023 โ‚ฌ0.50 B-468.52%
2022 -โ‚ฌ0.14 Billion449.24%
2021 -โ‚ฌ25.08 Million-68.04%
2020 -โ‚ฌ78.46 Million-52.1%
2019 -โ‚ฌ0.17 Billion64.49%
2018 -โ‚ฌ99.58 Million-15.04%
2017 -โ‚ฌ0.12 Billion-34.2%
2016 -โ‚ฌ0.18 Billion-5.34%
2015 -โ‚ฌ0.19 Billion35084.97%
2014 -โ‚ฌ0.54 Million
2012 โ‚ฌ6.62 M-117.81%
2011 -โ‚ฌ37.22 Million-12.69%
2010 -โ‚ฌ42.63 Million94.3%
2009 -โ‚ฌ21.94 Million-117.7%
2008 โ‚ฌ0.12 B622.63%
2007 โ‚ฌ17.15 M
2004 -โ‚ฌ67.83 Million-14.48%
2003 -โ‚ฌ79.32 Million11.88%
2002 -โ‚ฌ70.9 Million39.65%
2001 -โ‚ฌ50.77 Million5.73%
2000 -โ‚ฌ48.02 Million-28.91%
1999 -โ‚ฌ67.54 Million237.28%
1998 -โ‚ฌ20.03 Million100.05%
1997 -โ‚ฌ10.01 Million-37.93%
1996 -โ‚ฌ16.13 Million82.72%
1995 -โ‚ฌ8.83 Million-26.79%
1994 -โ‚ฌ12.06 Million-72.78%
1993 -โ‚ฌ44.29 Million208.07%
1992 -โ‚ฌ14.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ23.39 B 10,948.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ13.85 B 6,443.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ6.16 B 2,811.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ6.39 B 2,918.62%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚ฌ10.63 B 4,920.99%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ12.79 B 5,942.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-โ‚ฌ0.19 Billion-189.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-โ‚ฌ0.25 Billion-214.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.43 B 576.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel